Kura Oncology (KURA) Other Working Capital Changes (2014 - 2026)

Kura Oncology (KURA) has 13 years of Other Working Capital Changes data on file, last reported at -$9.4 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 127.3% year-over-year to -$9.4 million in Q1 2026; TTM through Mar 2026 was -$43.0 million, a 222.2% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 37.6% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$9.4 million, up from -$38.4 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for KURA reached as high as $10.3 million in Q3 2025 and fell as low as -$2.9 million in Q4 2025.
• Historically, Other Working Capital Changes has averaged $1.7 million across 5 years, with a median of $1.0 million in 2025.
• On a YoY basis, Other Working Capital Changes climbed as much as 20369.82% in 2025 and fell as far as 16433.62% in 2025.
• Year by year, Other Working Capital Changes stood at $17000.0 in 2022, then tumbled by 541.18% to -$75000.0 in 2023, then jumped by 413.33% to $235000.0 in 2024, then slumped by 16433.62% to -$38.4 million in 2025, then surged by 75.4% to -$9.4 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$9.4 million in Q1 2026, -$38.4 million in Q4 2025, and $15.7 million in Q3 2025.